Rising Cost Of PrEP, A Pill That Prevents HIV, Pushes It Out Of Reach For Many

Gilead Sciences makes Truvada, a medicine known generically as "pre-exposure prophylaxis," or PrEP. Consistent, daily doses of the drug are thought to reduce the risk of getting HIV from sex by more than 90 percent.

Many people at high risk for HIV can't afford PrEP, though it's more than 90 percent effective if taken daily. Its list price, close to $2,000 for a 30-day supply, has risen 45 percent in six years.

(Image credit: Paul Sakuma/AP)



from News : NPR https://ift.tt/2tEMBTw
https://ift.tt/2tSKdrA

Comentarii

Trimiteți un comentariu

Postări populare de pe acest blog

Covid inquiry defended despite scrutiny

Politicians including the treasurer have defended the government’s inquiry into the COVID-19 pandemic response, insisting it is a worthwhile exercise despite widespread condemnation it has been excluded from scrutinising the unilateral decisions made by each state. from Latest News and News Headlines | Daily Telegraph https://ift.tt/tsL8jh6 https://ift.tt/YLZWxQz
Citiți mai multe